Neurosciences -> Basic Science 1418

1418 - 4FMFES and FDG-PET of a ER+ uterine cancer mouse xenograft model (ID 1029)

Session Name
Oncology, Basic and Translational (Basic Science) Posters
Speakers
Authors
Presentation Topic
Neurosciences -> Basic Science
Presentation Number
1418

Previous Eposter
147 - 18F-FDG PET/CT IN LUNG CANCER PATIENTS UNDERGOING IMMUNOTHERAPY: A PRELIMINARY MONOCENTRIC EXPERIENCE (ID 827)

Next Eposters
1227 - 4FMFES-PET in ER+ lobular breast cancer: revealing what FDG-PET could not (ID 746)
1527 - TERT promoter mutation in a primary lesion of papillary thyroid carcinoma predicts absent or lower 131I uptake in a metastatic lesion (ID 1236)
587 - 68Ga-PSMA-11 PET/CT detects prostate cancer at early biochemical recurrence with superior detection rate and reader agreement when compared to 18F-Fluciclovine PET/CT in a prospective head-to-head comparative phase 3 study< (ID 1281)
1009 - A new PET imaging agent for monitoring HER2 status using Trastuzumab antibody conjugated with a novel 89 Zr-chelator. (ID 61)
2006 - Added Value of Digital over Analog PET: A Technologist Perspective (ID 263)
1423 - Association of gastric wall tracer uptake with proton pump inhibitor use in patients undergoing 99mTc-sestamibi myocardial perfusion scintigraphy (ID 1105)
619 - Automated PET/CT radiomic analysis with machine learning for identifying bone marrow involvement in the patients with suspected relapsed acute leukemia (ID 583)
217 - Close correlation in cancer patients between diffusely decreased liver uptake on FDG-PET & cancer-associated cachexia (ID 919)
351 - Combination of 177Lu-lilotomab satetraxetan with rituximab synergistically improves in-vivo therapeutic efficacy in a rituximab-resistant non-Hodgkin lymphoma (NHL) model (ID 1000)
77 - Combined PRLT using Ac-225 and Lu-177 labeled PSMA-617 (TANDEM-PRLT) in end-stage metastatic prostate cancer: a concept to reduce salivary gland toxicity? (ID 421)